← Leaderboards
Mark William Friedberg
Rand Corporation
$455,285
Attributed
$455,285
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $240.6K · FY2017–18$250K$187.5K$125K$62.5K$0
'17
'18
Funding mix
By agency
NIH$455,285 · 1
By mechanism
R21$455,285 · 1
Top collaborators
No co-investigators on record.
Most similar at Rand Corporation
Same institution · by research overlap
- Dana P Goldman$26,931,376
- Ronald Dale Hays$27,577,840
- Ian Douglass Coulter$14,404,308
- Neeraj Sood$6,080,333
- Christopher Whaley$2,563,210
Others in their field
Other Emerging Leaders on “Adverse Drug Event”
- Susan Abushakra · Alzheon, Inc.$47,690,244
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,144,108
- Caroline Sigman · Ccs Associates, Inc.$13,846,650
- Andrew S Huhn · Johns Hopkins University$12,205,195
- Mary E Hamby · Cognition Therapeutics, Inc.$9,832,688
- Elizabeth Fox · St. Jude Children'S Research Hospital$8,840,232
Research focus
Adverse Drug EventEffectivenessAffectAgedAcademic DetailingBaseBeerBehaviorBehavioral EconomicsBeneficiaryAntibioticsAdverse EventClinicClinical PharmacistsCluster Randomized TrialCognitiveCombination MedicationCostCountryDecision MakingDesignDrug InteractionsEducationElderly